- 股價
13.00
- 漲跌
--
- 漲幅
0.00%
- 成交量
55張
- 產業
興櫃 生技醫療業
0.00%
-
本地時間:13:36(已收盤)
月營收報表
因應IFRSs國際會計準則,本報表在2013年以前為「個別營收」,2013年以後為「合併營收」。
通用幹細胞* (7607) 月營收報表
| 年度/月份 | 營業收入(單位:千元) | 累計營業收入(單位:千元) |
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 |
| 2026/04 | 1,726 | 6,414 | -27.8% | -73.1% | 5,596 | 8,762 | -36.1% |
| 2026/03 | 2,390 | 1,009 | 409.6% | 136.9% | 3,870 | 2,348 | 64.8% |
| 2026/02 | 469 | 778 | -53.6% | -39.7% | 1,480 | 1,339 | 10.5% |
| 2026/01 | 1,011 | 561 | 5.4% | 80.2% | 1,011 | 561 | 80.2% |
| 2025/12 | 959 | 826 | -38.3% | 16.1% | 20,693 | 12,052 | 71.7% |
| 2025/11 | 1,554 | 1,129 | -5.5% | 37.6% | 19,734 | 11,226 | 75.8% |
| 2025/10 | 1,644 | 1,182 | -42.8% | 39.1% | 18,180 | 10,097 | 80.1% |
| 2025/09 | 2,875 | 1,235 | 54.4% | 132.8% | 16,536 | 8,915 | 85.5% |
| 2025/08 | 1,862 | 1,570 | 33.5% | 18.6% | 13,661 | 7,680 | 77.9% |
| 2025/07 | 1,395 | 1,018 | 38.1% | 37% | 11,798 | 6,110 | 93.1% |
| 2025/06 | 1,010 | 753 | 60.1% | 34.1% | 10,404 | 5,092 | 104.3% |
| 2025/05 | 631 | 802 | -90.2% | -21.3% | 9,394 | 4,339 | 116.5% |
| 2025/04 | 6,414 | 986 | 535.7% | 550.5% | 8,762 | 3,537 | 147.7% |
| 2025/03 | 1,009 | 1,104 | 29.7% | -8.6% | 2,348 | 2,551 | -7.9% |
| 2025/02 | 778 | 119 | 38.7% | 553.8% | 1,339 | 1,447 | -7.5% |
| 2025/01 | 561 | 1,328 | -32.1% | -57.8% | 561 | 1,328 | -57.8% |
| 2024/12 | 826 | 913 | -26.8% | -9.5% | 12,052 | 13,667 | -11.8% |
| 2024/11 | 1,129 | 1,134 | -4.5% | -0.4% | 11,226 | 12,754 | -12% |
| 2024/10 | 1,182 | 979 | -4.3% | 20.7% | 10,097 | 11,620 | -13.1% |
| 2024/09 | 1,235 | 1,068 | -21.3% | 15.6% | 8,915 | 10,640 | -16.2% |
| 2024/08 | 1,570 | 565 | 54.2% | 177.9% | 7,680 | 9,572 | -19.8% |
| 2024/07 | 1,018 | 1,700 | 35.2% | -40.1% | 6,110 | 9,007 | -32.2% |
| 2024/06 | 753 | 798 | -6.1% | -5.6% | 5,092 | 7,307 | -30.3% |
| 2024/05 | 802 | 1,483 | -18.7% | -45.9% | 4,339 | 6,509 | -33.3% |
| 2024/04 | 986 | 1,374 | -10.7% | -28.2% | 3,537 | 5,026 | -29.6% |
| 2024/03 | 1,104 | 2,101 | 827.7% | -47.5% | 2,551 | 3,652 | -30.1% |
| 2024/02 | 119 | 1,020 | -91% | -88.3% | 1,447 | 1,550 | -6.6% |
| 2024/01 | 1,328 | 530 | 45.5% | 150.6% | 1,328 | 530 | 150.6% |
| 2023/12 | 913 | 654 | -19.5% | 39.6% | 13,667 | 6,862 | 99.2% |
| 2023/11 | 1,134 | 783 | 15.8% | 44.8% | 12,754 | 6,208 | 105.4% |
| 2023/10 | 979 | 1,042 | -8.3% | -6% | 11,620 | 5,425 | 114.2% |
| 2023/09 | 1,068 | 268 | 89% | 298.5% | 10,640 | 4,382 | 142.8% |
| 2023/08 | 565 | 818 | -66.8% | -30.9% | 9,572 | 4,114 | 132.7% |
| 2023/07 | 1,700 | 1,006 | 113% | 69% | 9,007 | 3,296 | 173.3% |
| 2023/06 | 798 | 551 | -46.2% | 44.8% | 7,307 | 2,290 | 219.1% |
| 2023/05 | 1,483 | 259 | 0% | 472.6% | 6,509 | 1,739 | 274.3% |
新加坡第一季GDP遠高於預期 但警告全球地緣政治加劇風險Anue鉅亨-1天前
日股首度漲破6.5萬點 外資瘋湧:上漲空間才剛打開Anue鉅亨-1天前
外資連12賣韓股!上周淨賣超三星、SK海力士2435億台幣 專家:槓桿ETF上路恐加劇市場波動Anue鉅亨-1天前